Infectious Diseases (all articles)
Viewpoint: Sensible medicine—balancing intervention and inaction during the COVID-19 pandemic
16 Oct, 2020 | 09:38h | UTCSensible Medicine—Balancing Intervention and Inaction During the COVID-19 Pandemic – JAMA
Author interview: Sensible Medicine—Balancing Intervention and Inaction During the COVID-19 Pandemic
Commentary on Twitter
https://twitter.com/seymoc/status/1316765788523511809
Act now, wait for perfect evidence later, says ‘high priestess’ of U.K. COVID-19 masking campaign
16 Oct, 2020 | 09:37h | UTC
Commentary on Twitter
Profile of @trishgreenhalgh, whose laudable and herculean efforts have favorably influenced our response to the pandemic @ScienceMagazine @UniofOxford https://t.co/t4yTFgmbr2 by @EllenRuppelShel
“As scientists, our goal must be to cut through the rubbish.”— Eric Topol (@EricTopol) October 15, 2020
Cochrane living systematic review: Not enough evidence to recommend convalescent plasma for people with COVID‐19
16 Oct, 2020 | 09:34h | UTC
Commentary on Twitter
Just updated: @CochraneCollab living review investigates the use of convalescent plasma to treat people with COVID-19: https://t.co/Or5qmxki8H “We remain very uncertain about the effectiveness & safety of using convalescent plasma for people with #COVID19".
— The Cochrane Library (@CochraneLibrary) October 13, 2020
Review: Why and how vaccines work
16 Oct, 2020 | 09:32h | UTCWhy and How Vaccines Work – Cell
Commentary on Twitter
Why and how vaccines work, including how the covid-19 vaccines are positioned, new adjuvants
New @CellCellPress by @VirusesImmunity and @SaadOmer3 https://t.co/ydGfLJh0Uv pic.twitter.com/8niIaMVlAQ— Eric Topol (@EricTopol) October 15, 2020
IDSA Position Statement: “Herd immunity” is not an answer to a pandemic
15 Oct, 2020 | 09:31h | UTC“Herd Immunity” is Not an Answer to a Pandemic – Infectious Diseases Society of America
Commentary on Twitter
https://t.co/k15V8bMjiK via @IDSAInfo Excellent statement from @IDSAInfo & @HIVMA Presidents of why "herd immunity" is not an answer to a pandemic. These is the professional association representing > 12K specialists in infectious diseases so these are the real experts!
— Carlos del Rio (@CarlosdelRio7) October 14, 2020
Perspective: Will SARS-CoV-2 become endemic?
15 Oct, 2020 | 09:29h | UTCWill SARS-CoV-2 become endemic? – Science
Commentary on Twitter
Whether #SARSCoV2 reinfections will be commonplace and how often they will occur remain to be understood, say authors in this Perspective. They also discuss what factors could drive the resultant pattern of endemicity if reinfection does become common. https://t.co/POKQ2byTYB pic.twitter.com/FMNbB8QR6p
— Science Magazine (@ScienceMagazine) October 14, 2020
Living with the COVID-19 pandemic: Act now with the tools we have
15 Oct, 2020 | 09:22h | UTCLiving with the COVID-19 pandemic: act now with the tools we have – The Lancet
Commentary on Twitter
NEW—Living with the #COVID19 pandemic: act now with the tools we have
J Bedford et al, @WHO STAG-IH, share a checklist for an epidemiologically based public health response to COVID-19, which is "neglected or inappropriately understood in some countries" https://t.co/vhjY0MsekB pic.twitter.com/Vb3B8OJNjr
— The Lancet (@TheLancet) October 9, 2020
Review: The duration of infectiousness of individuals infected with SARS-CoV-2
15 Oct, 2020 | 09:26h | UTCThe duration of infectiousness of individuals infected with SARS-CoV-2 – Journal of Infection
Commentary on Twitter
🔥NEW Review🔥#COVID19 pts with mild-to-moderate illness are highly unlikely to be infectious beyond 10 ds from symptom onset , However, limited studies found that Immunocompromised and severe-to-critical patients may be infectious for >10 days https://t.co/hogXvFpPEb pic.twitter.com/fBm5Se4RBf
— Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 (@ABsteward) October 13, 2020
Coronavirus vaccine: What we know so far – a comprehensive guide by academic experts
15 Oct, 2020 | 09:17h | UTC
The 4 simple reasons Germany is managing Covid-19 better than its neighbors
15 Oct, 2020 | 09:19h | UTCThe 4 simple reasons Germany is managing Covid-19 better than its neighbors – Vox
See also: The German coronavirus mystery – UnHerd
WHO Global tuberculosis report 2020
15 Oct, 2020 | 09:35h | UTCGlobal tuberculosis report 2020 – World Health Organization
News release: WHO: Global TB progress at risk – World Health Organization
Executive summary: Global tuberculosis report 2020
Commentary: WHO warns of COVID impact on TB services – CIDRAP
Commentary on Twitter
The 🌏🌍🌏 has made steady progress in tackling tuberculosis (TB), with a 1⃣4⃣% drop in deaths between 2015 and 2019.
🚨 #COVID19 will lead to setbacks if no action is taken urgently, according to 🆕 WHO report 👉https://t.co/5BvbGjaudU pic.twitter.com/A4edYfyOBH
— World Health Organization (WHO) (@WHO) October 14, 2020
Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2020 Recommendations of the International Antiviral Society–USA Panel
15 Oct, 2020 | 09:13h | UTC
Commentary on Twitter
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults https://t.co/J3zHm9rpkY via @JAMA_current The new @IAS_USA ART guidelines document is out. Enormous effort led by @msaagmd with @RMKGandhi @doc_in_a_box @drmt @PaulSaxMD @joseph_eron and others on panel.
— Carlos del Rio (@CarlosdelRio7) October 14, 2020
Phase 3 trials show positive results for cefiderocol, but questions remain
15 Oct, 2020 | 09:07h | UTCPhase 3 trials show positive results for cefiderocol, but questions remain – CIDRAP
Genomic evidence for reinfection with SARS-CoV-2: A case study
14 Oct, 2020 | 09:39h | UTCGenomic evidence for reinfection with SARS-CoV-2: a case study – The Lancet Infectious Diseases
Commentaries: First Case Of COVID-19 Reinfection In The US Confirmed; Exposure to Virus May Not Guarantee Protective Immunity, Says New Lancet Study – Health Policy Watch AND What reinfections mean for COVID-19 – The Lancet Infectious Diseases AND You can get reinfected with Covid-19 but still have immunity. Let’s explain. – Vox AND A 25-Year-Old Nevada Man Got COVID-19 Twice. Here’s What We Know—and Don’t Know—About Reinfection – TIME
Related: Dutch woman dies after catching Covid-19 twice, the first reported reinfection death – CNN
Updated NIH COVID-19 Treatment Guidelines
14 Oct, 2020 | 09:41h | UTCCoronavirus Disease 2019 (COVID-19) Treatment Guidelines – National Institutes of Health
See also: What’s New in the Guidelines
COVID-19 in New Zealand and the impact of the national response: A descriptive epidemiological study
14 Oct, 2020 | 09:38h | UTCCommentary: Lessons from New Zealand’s COVID-19 outbreak response – The Global Health
Commentary on Twitter
How New Zealand crushed covid: rapid, aggressive use of masks, distancing, testing, isolation, travel ban. Hard work.
Transmission chains notable (wedding, school clusters)https://t.co/FMCgQOsVYJhttps://t.co/svRZyjvOf2 @AlxsRobert @TheLancetPH 🇳🇿👏👏 pic.twitter.com/WqxAySjqJy— Eric Topol (@EricTopol) October 14, 2020
COVID-19 and cancer: Current challenges and perspectives
14 Oct, 2020 | 09:35h | UTCCOVID-19 and Cancer: Current Challenges and Perspectives – Cancer Cell
Johnson & Johnson Covid-19 vaccine study paused due to unexplained illness in participant
14 Oct, 2020 | 09:31h | UTCJohnson & Johnson Covid-19 vaccine study paused due to unexplained illness in participant – STAT
News Release: Johnson & Johnson Temporarily Pauses All Dosing in Our Janssen COVID-19 Vaccine Candidate Clinical Trials
Commentaries: Johnson & Johnson ‘Pauses’ COVID-19 Vaccine Trial Due To Unexplained Illness In Participant; Eli Lilly Reportedly Suspending Trial Of Antibody Treatment – Health Policy Watch AND Johnson & Johnson pauses Covid-19 vaccine trial after ‘unexplained illness’ – CNN
Non-respiratory presentations of COVID-19, a clinical review
14 Oct, 2020 | 09:33h | UTC
Monoclonal antibody trial halted for safety concern
14 Oct, 2020 | 09:30h | UTCMonoclonal Antibody Trial Halted for Safety Concern – Brief19
Covid-19: how to prioritize worse-off populations in allocating safe and effective vaccines
14 Oct, 2020 | 09:25h | UTC
COVID-19 will probably become endemic – here’s what that means
14 Oct, 2020 | 09:27h | UTCCOVID-19 will probably become endemic – here’s what that means – The Conversation
[Abstract Only] Randomized trials: Efficacy and safety of a plant-derived influenza vaccine in adults
14 Oct, 2020 | 09:23h | UTCEfficacy, immunogenicity, and safety of a plant-derived, quadrivalent, virus-like particle influenza vaccine in adults (18–64 years) and older adults (≥65 years): two multicentre, randomised phase 3 trials – The Lancet (link to abstract – $ for full-text)
Commentary on Twitter
NEW—First large-scale studies of plant-derived, quadrivalent, virus-like particle influenza vaccine show substantial protection against respiratory illness & influenza-like illness caused by influenza viruses in adults: two randomised phase 3 trials https://t.co/oQbs2uJTXY pic.twitter.com/C6b6Qi6qZ7
— The Lancet (@TheLancet) October 13, 2020
Case report: Sudden irreversible hearing loss post COVID-19
14 Oct, 2020 | 09:24h | UTCSudden irreversible hearing loss post COVID-19 – BMJ Case Reports
Commentaries: Coronavirus: Patient has sudden permanent hearing loss – BBC AND First reported UK case of sudden permanent hearing loss linked to COVID-19 – BMJ
Commentary on Twitter
Sudden hearing loss after #COVID19.
Report of 1st UK case and review of the other 4 published reports (must be *extremely rare*)https://t.co/wCkrgHcwKH pic.twitter.com/onQxxYiImb— Eric Topol (@EricTopol) October 13, 2020
Opinion piece by Dr. John P.A. Ioannidis: Global perspective of COVID‐19 epidemiology for a full‐cycle pandemic
13 Oct, 2020 | 01:15h | UTC